# Tesamorelin / MGF / Ipamorelin Blend

> This blend combines tesamorelin and ipamorelin, both studied for systemic GH/IGF-1 axis stimulation, with mechano growth factor (MGF), a splice variant of IGF-1 proposed to be locally expressed in skeletal muscle following mechanical stress or exercise-induced damage. MGF is the least established of the three components: most available information comes from animal studies and small mechanistic research rather than controlled human trials, and MGF is widely reported to be unstable once reconstituted. Of the growth-hormone blends discussed here, this combination has the most limited overall research base. It is primarily discussed in bodybuilding-adjacent research contexts rather than clinical literature, and it is not approved for human medical use.

- URL: https://www.lifeconverted.com/peptides/tesamorelin-mgf-ipamorelin-blend
- Also known as: Tesa/MGF/Ipa Blend
- Primary category: GH Blends
- Effectiveness rank: #18 in Muscle & Performance; #999 in Growth Hormone Peptides; #999 in GH Releasing Hormones; #8 in GH Blends
- Evidence level: Emerging research
- Route: Subcutaneous (Injected subcutaneously; some protocols dose the MGF component separately, immediately after exercise, rather than at the same fixed daily time as tesamorelin and ipamorelin.)
- Dose range: 1,000-2,500 mcg
- Dose tiers: low 1000 mcg; moderate 1800 mcg; high 2500 mcg
- Half-life: Tesamorelin is reported at roughly 25-40 minutes and ipamorelin at roughly 2 hours; MGF is reported to be extremely short-lived and unstable in solution, on the order of minutes, which is why some protocols reconstitute and dose it separately close to the time of use.
- Timing: ~30 min before bed, empty stomach
- Cycle: 6-8 weeks on, 6-8 weeks off (Shorter cycles than other GH blends are often suggested given the comparatively limited data on the MGF component.)
- Storage: Refrigerate the tesamorelin/ipamorelin portion after reconstitution (2-8°C). MGF in particular is described as losing activity quickly once reconstituted, so some protocols prepare only the amount needed shortly before use.

## Mechanism of action

Tesamorelin and ipamorelin stimulate the systemic GH/IGF-1 axis via GHRH- and ghrelin-receptor pathways, respectively, as described for other blends in this category. MGF is proposed, based on preclinical work, to act locally within mechanically stressed muscle tissue to help trigger satellite cell activation and proliferation, a pathway distinct from circulating IGF-1 generated by liver GH signaling. Proponents describe the combination as pairing systemic GH-axis stimulation with a locally acting muscle-repair signal, though the degree of interaction between systemic and local IGF-1 pathways in humans has not been established.

## Reported benefits

- Systemic growth-hormone axis stimulation
- Proposed local muscle-repair signaling from the MGF component
- Research interest in post-exercise recovery
- Supports body composition research goals

## Reported side effects

- Injection site irritation
- Water retention
- Joint or muscle discomfort
- Inconsistent effect from the MGF component due to reported instability in solution
- Overall limited safety data relative to more established secretagogue blends

## Common protocols

- Post-Workout Recovery Stack
- Muscle Growth Research Protocol

## Stacking notes

MGF has the most limited human research base of the components in this blend; it is frequently discussed in bodybuilding-adjacent contexts but lacks the clinical trial evidence of tesamorelin or the longer secretagogue research history of ipamorelin.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer